Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2024 for the treatment of colorectal cancer
International Journal of Clinical Oncology · 2025-12 · 30 (12) · 2410-2463
DOI: 10.1007/s10147-025-02899-8 ↗Kurz gefasst
Leitlinie in der Zeitschrift International Journal of Clinical Oncology, online erschienen am 04.11.2025. Verfasst von Yusuke Kinugasa und 31 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Institute of Science Tokyo (Science Tokyo) Graduate School, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan…. Hauptthemen laut MEDLINE: Colorectal Neoplasms. Die Arbeit wurde bisher 88-mal zitiert (Crossref) und nennt 409 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The number of deaths from colorectal cancer in Japan continues to rise, with over 50,000 deaths recorded in 2018. In the 2024 edition, revisions to all aspects of treatment were undertaken, with corrections and additions made based on knowledge gained since the 2022 version (drug therapy) and the 2019 version (other treatments). The Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2024 for the treatment of colorectal cancer have been prepared to present standard treatment strategies, reduce disparities among institutions, avoid both unnecessary and insufficient treatment, and enhance mutual understanding between healthcare professionals and patients by making these guidelines accessible to the public. These guidelines were developed through consensus by the JSCCR Guideline Committee, following a careful review of evidence retrieved from literature searches and considering the medical insurance system and actual clinical practice in Japan. Therefore, these guidelines serve as a tool for managing colorectal cancer in real-world clinical settings. More specifically, they can be used to support obtaining informed consent from patients and selecting the most appropriate treatment method for each patient. Controversial topics were selected as clinical questions, and recommendations were provided. Each recommendation is accompanied by an evidence classification and a recommendation category, both based on consensus reached by the Guideline Committee members. This article presents the English version of the JSCCR guidelines 2024.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery, Institute of Science Tokyo (Science Tokyo) Graduate School, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan. kinugasa.srg1@tmd.ac.jp.
- Department of Gastroenterological Surgery, Nippon Medical School, Tokyo, Japan.
- Department of Gastroenterological Chemotherapy, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.
- Endoscopy Division, National Cancer Center Hospital, Tokyo, Japan.
- Division of Radiation Oncology, Department of Radiology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
- Pathology, Southern Tohoku Research Institute for Neuroscience Southern Tohoku General Hospital, Fukushima, Japan.
Zitieren
APA
Kinugasa, Y., Uehara, K., Yamaguchi, K., Saito, Y., Murofushi, K., Sugai, T., Ishiguro, M., Ishihara, S., Ueno, H., Oka, S., Kato, T., Kanemitsu, Y., Kawakami, H., Kobayashi, H., Sakamoto, Y., Shiozawa, M., Shiomi, A., Shinozaki, E., Takiyama, H., …, & Japanese Society for Cancer of the Colon and Rectum (2025). Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2024 for the treatment of colorectal cancer. International Journal of Clinical Oncology, 30(12), 2410-2463. https://doi.org/10.1007/s10147-025-02899-8
Vancouver
Kinugasa Y, Uehara K, Yamaguchi K, Saito Y, Murofushi K, Sugai T, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2024 for the treatment of colorectal cancer. International Journal of Clinical Oncology. 2025;30(12):2410-2463. doi:10.1007/s10147-025-02899-8
BibTeX
@article{Kinugasa2025,
author = {Kinugasa, Yusuke and Uehara, Kay and Yamaguchi, Kensei and Saito, Yutaka and Murofushi, Keiko and Sugai, Tamotsu and Ishiguro, Megumi and Ishihara, Soichiro and Ueno, Hideki and Oka, Shiro and Kato, Takeshi and Kanemitsu, Yukihide and Kawakami, Hisato and Kobayashi, Hirotoshi and Sakamoto, Yoshihiro and Shiozawa, Manabu and Shiomi, Akio and Shinozaki, Eiji and Takiyama, Hirotoshi and Taniguchi, Hiroya and Nakajima, Takako Eguchi and Hotta, Kinichi and Matsuda, Keiji and Murata, Kohei and Morita, Satoshi and Yamazaki, Kentaro and Yoshida, Masahiro and Yamaguchi, Naohiko and Kagawa, Hiroyasu and Yamauchi, Shinichi and Ajioka, Yoichi and Japanese Society for Cancer of the Colon and Rectum, Japanese Society for Cancer of the Colon and Rectum},
title = {Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2024 for the treatment of colorectal cancer},
journal = {International Journal of Clinical Oncology},
year = {2025},
volume = {30},
number = {12},
pages = {2410--2463},
doi = {10.1007/s10147-025-02899-8}
}
EUVIMED